medigraphic.com
Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.

2022, Número 1

<< Anterior Siguiente >>

Arch Med Fam 2022; 24 (1)


Potenciales secuelas en la salud por Covid-19 en México: ¿Qué debemos de esperar?

Torres-Cuevas JL, Gil-Guzmán OA, Torres-Escalante JL

Idioma: Español
Referencias bibliográficas: 46
Paginas: 67-73
Archivo PDF: 152.93 Kb.


RESUMEN

A casi un año del inicio de la pandemia por COVID-19 aún existen muchas interrogantes en materia de salud que desconocemos. A partir de lo observado en brotes epidémicos previos por diferentes coronavirus y lo publicado hasta la fecha con relación al SARS-CoV2. Se han identificado diferentes secuelas secundarias a COVID-19 que afectan a la salud física y mental tanto a mediano como a largo plazo en un porcentaje significativo de los sobrevivientes. Debido a que las secuelas se asocian a comorbilidades y características socioeconómicas de importante prevalencia en México, se podría esperar una mayor frecuencia de estas complicaciones en comparación con otros países. Es necesario que el sistema de salud nacional genere estrategias dirigidas a las complicaciones secundarias a COVID-19.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242.

  2. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L & Favre G. Real estimates of mortality following COVID-19 infection. The Lancet Infectious diseases. 2020; 20(7), 773.

  3. Carfì A, Bernabei R, Landi F, for the gemelli against COVID-19 post-acute care study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603–605.

  4. Salehi S, Reddy S, Gholamrezanezhad A. Long-term pulmonary consequences of Coronavirus Disease 2019 (COVID-19). Journal of thoracic imaging. 2020; 35(4): W87-W89.

  5. Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. American Journal of Emergency Medicine. 2020; 38(7):1504-1507.

  6. Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. The Lancet Psychiatry. 2020; 7(10): 875- 882.

  7. Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a singlecentre longitudinal study. Clin Microbiol Infect. 2020; 27(1): 89-95.

  8. Wu X, Dong D, Ma D. Thin-section computed tomography manifestations during convalescence and long-term follow-up of patients with Severe Acute Respiratory Syndrome (SARS). Med sci monit. 2016;22:2793-2799.

  9. Zhang P, Li J, Liu H, Han N, Ju J, Kou Y, et al. Long-term bone and lung consequences associated with hospitalacquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res. (2020); 8: 8.

  10. Das KM, Lee EY, Singh R, Enani MA, Al Dossari K, Van Gorkom K, et al. Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian J Radiol Imaging. 2017;27(3):342-349.

  11. Ojo AS, Balogun SA, Williams OT, Ojo OS. Pulmonary fibrosis in COVID-19 survivors: predictive factors and risk reduction strategies. Pulmonary Medicine. 2020; 2020: 6175964.

  12. Vasarmidi E, Tsitoura E, Spandidos DA, Tzanakis N, Antoniou KM. Pulmonary fibrosis in the aftermath of the Covid- 19 era (Review). Experimental and therapeutic medicine. 2020; 3:2557-2560.

  13. Zhao Y, Shang Y, Song W, Li Q, Xie H, Xu Q, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020; 25: 100463.

  14. Encuesta Nacional de Salud y Nutrición. Encuesta Nacional de Salud y Nutrición 2018-2019 resultados nacionales [monofrafía en internet]. México: ENSANUT 2020. [consultado en 2020 noviembre]. Disponible en: https://ensanut.insp.mx/encuestas/ensanut2018/doctos/informes/ensanut_2018_informe_final.pdf

  15. Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D, Della Casa G, et al. Pulmonary fibrosis secondary to COVID-19: a call to arms?. The Lancet Respiratory Medicine. 2020; 8(8): 750-752.

  16. Nishiyama O, Kondoh Y, Kimura T, Kato K, Kataoka K, Ogawa T, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008; 13:394-399.

  17. Swigris JJ, Fairclough DL, Morrison M, Make B, Kozora E, Brown KK, et al. Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis. Respir Care. 2011; 56(6): 783-789.

  18. Garrigues E, Janvier P, Kherabi Y, Bot AL, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. Journal of Infection. 2020; 81(6): 4-6.

  19. French CL, Irwin RS, Curley FJ, Krikorian CJ. Impact of Chronic Cough on Quality of Life. Arch Intern Med. 1998;158(15):1657–1661.

  20. Cass A, Mansur A, Vigus A. P161 Chronic pain is prevalent in severe asthma and is associated with impairment in patient’s activityThorax. 2019;74:A178.

  21. Rajala K, Lehto JT, Sutinen E, Kautiainen H, Myllärniemi M, Saarto T. mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis. ERJ open research. 2017; 3(4).

  22. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265–1273.

  23. Anzini M, Merlo M, Sabbadini G, Barbati G, Finocchiaro G, Pinamonti B, et al. Long-term evolution and prognostic stratification of biopsy-proven active myocarditis. Circulation. 2013;128(2):2384–2394.

  24. Peretto G, Sala S, Rizzo S, Palmisano A, Esposito A, De Cobelli F, et al. Ventricular arrhythmias in myocarditis: characterization and relationships with myocardial inflammation. J Am Coll Cardiol. 2020;75(9)1046-1057.

  25. Chang JJ, Lin MS, Chen TH, Chen DY, Chen SW, Hsu JT, et al. Heart failure and mortality of adult survivors from acute myocarditis requiring intensive care treatment - A nationwide cohort study. Int J Med Sci. 2017;14(2):1241- 1250.

  26. Chang TY, Chao TF, Liu CJ, Chen SJ, Chung FP, Liao JN, et al. The association between influenza infection, vaccination, and atrial fibrillation: A nationwide case-control study. Hear Rhythm. 2016;13(6):1189-1194.

  27. Becker R. COVID􀇦19 update: Covid􀇦19􀇦associated coagulopathy. J Thromb Thrombolysis.2020;50(1):54-67.

  28. Wu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J, et al. Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection. Sci Rep. 2017;7:9110.

  29. Instituto Nacional de Estadística y Geografía. Características de las defunciones registradas en México en 2018 [monografía en internet]. México: INEGI 2019. [consultado en 2020 noviembre]. Disponible en: https://www.inegi.org.mx/contenidos/saladeprensa/boletines/2019/EstSociodemo/DefuncionesRegistradas2019.pdf

  30. Castro-Juárez CJ, Cabrera-Pivaral CE, Ramírez-García SA, García-Sierra L, Morales-Pérez L, Ramírez-Concepción HR. Factores de riesgo para enfermedad cardiovascular en adultos mexicanos. Rev Med MD. 2017;8.9(2):152-162.

  31. Henry J, Smeyne RJ, Jang H, Miller B, Okun MS. Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuries. Parkinsonism Relat Disord. 2010;16(9):566-571.

  32. Koppolu V, Shantha-Raju T. Zika virus outbreak: a review of neurological complications, diagnosis, and treatment options. J NeuroVirolo. 2018; 24:255-272.

  33. Lam MH, Wing Y, Yu MW, Leung C, Ma RC, Kong AP, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169(22):2142-2147.

  34. Lambert, N. J. & Survivor Corps. COVID-19 “Long Hauler” Symptoms Survey Report. Indiana University School of Medicine; 2020.

  35. Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020. https://doi.org/10.1371/journal.pone.0240784.

  36. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77 (6):683-690.

  37. Ntaios G, Michel P, Georgiopoulos G, Guo Y, Li W, Xiong J, et al. Characteristics and Outcomes in Patients with COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry. Stroke. 2020;Sep;51(9):e254-e258.

  38. An Analysis of the Prolonged COVID-19 Symptoms Survey by Patient-Led Research Team.[internet] Patient Led Research For COVID-19; publicado el 11 de mayo del 2020 [citado el 2020 Dec 01];Disponible en: https://patientresearchcovid19.com/research/report-1/

  39. Herridge MS, Moss M, Hough CL, Hopkins RO, Rice TW, Bienvenu OJ, et al. Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers. Intensive Care Medicine. 2016;May;42(5):725-738.

  40. Esquivel G. Los impactos económicos de la pandemia en México. EconomíaUNAM. 2020;17(51):41-Instituto Nacional de Estadística y Geografía (INEGI) [internet]. Salud y seguridad social: Salud Mental [citado el 10 dic del 2020]. Disponible en: https://www.inegi.org.mx/temas/salud/

  41. Dinakaran D, Manjunatha N, Naveen Kumar C, Suresh BM. Neuropsychiatric aspects of COVID-19 pandemic: A selective review. Asian Journal of Psychiatry. 2020;53:102188.

  42. Miller AH, Raison CL. The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nature Reviews Immunology. 2016;16(1):22-34.

  43. Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network. MMWR Morb Mortal Wkly Rep. 2020;69(30);993-998.

  44. Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract. 2020;39:101166.

  45. Gobierno de México [internet] Covid-19 México [citado el 23 de diciembre del 2020]. Disponible en: https://datos.covid-19.conacyt.mx/

  46. Contreras-Andrade R, Juárez-González L , Arellano-Montellano E, & Herrera-García, J. (2020). Persistencia de síntomas en pacientes después de la enfermedad por coronavirus (COVID-19) en un hospital de tercer nivel de Puebla, México. Medicina Interna de México. 2020;36(6) 789-793.




2020     |     www.medigraphic.com